...
首页> 外文期刊>Journal of Clinical Medicine >A Novel Technique of Endoscopic Papillectomy with Hybrid Endoscopic Submucosal Dissection for Ampullary Tumors: A Proof-of-Concept Study (with Video)
【24h】

A Novel Technique of Endoscopic Papillectomy with Hybrid Endoscopic Submucosal Dissection for Ampullary Tumors: A Proof-of-Concept Study (with Video)

机译:具有杂交内镜粘膜粘膜瘤瘤瘤瘤瘤瘤的新型技术:概念验证研究(视频)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Endoscopic papillectomy (EP) carries a potential risk of procedure-related adverse events and incomplete resection. Since hybrid endoscopic submucosal dissection (ESD) had been established as an alternative option for relatively large and difficult gastrointestinal tumors, we evaluated a novel EP with hybrid ESD (hybrid ESD-EP) for curative safe margin in this proof-of-concept study. Methods: A total of eight cases who underwent hybrid ESD-EP between 2018 and 2020 were identified from our prospectively maintained database. Hybrid ESD-EP involved a (sub)circumferential incision with partial submucosal dissection, and subsequent snare resection of ampullary tumors, which was performed by two endoscopists with expertise in ESD or endoscopic retrograde cholangiopancreatography. Demographic data and clinicopathological outcomes were retrospectively evaluated. Results: En bloc resection was achieved by hybrid ESD-EP in all eight cases, with the median procedure time of 112 (range: 65–170) minutes. The median diameters of the resected specimens and tumors were 18 and 12 mm, respectively. All lateral margins were clear, whereas vertical margin was uncertain in three (38%), resulting in the complete resection rate of 63%. Postoperative bleeding and pancreatitis developed in each one (13%). No tumor recurrence was observed even in those cases with uncertain vertical margin, after a median follow-up of 244 (range, 97–678) days. Conclusions: Hybrid ESD-EP seems to be feasible and promising in ensuring the lateral resection margin. However, further investigations, especially to secure the vertical margin and to shorten the procedure time, should be required.
机译:背景:内镜下乳头切除术(EP)携带潜在的程序相关不良事件和不完全切除的风险。由于杂化内镜粘膜粘膜释放(ESD)作为相对较大且难以胃肠道肿瘤的替代选择,我们将新型EP与杂交ESD(混合ESD-EP)进行评估,以便在该概念证明研究中进行治疗安全保证金。方法:从我们的前瞻性维护数据库中确定了2018年和2020年间杂交ESD-EP的八个案例。杂交ESD-EP涉及(亚)圆周切口,具有部分粘膜粘膜解剖,随后的脉冲切除术肿瘤,其在两个内窥镜手中进行了ESD或内窥镜逆行胆管痴呆症的专业知识。回顾性评估人口统计数据和临床病理结果。结果:EN Bloc切除在所有八种情况下通过杂交ESD-EP实现,中位程序时间为112(范围:65-170)分钟。切除的样品和肿瘤的中位数分别为18和12mm。所有横向边缘都很清晰,而垂直边距在三(38%)中不确定,导致完全切除率为63%。术后出血和胰腺炎,每一个(13%)开发。甚至在垂直边缘的不确定的情况下,在244(范围97-678)天后,甚至在这些情况下观察到肿瘤复发。结论:杂交ESD-EP似乎是可行的,并且在确保横向切除余量方面是可行的和有希望的。然而,应该需要进一步调查,特别是为了确保垂直边缘并缩短程序时间。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号